Why Bill Ackman Bet $2.3 Billion That the Market Is Dead Wrong
In early 2025, billionaire investor Bill Ackman, CEO of Pershing Square Capital Management, revealed a substantial new position in Uber Technologies. By January, Pershing Square had accumulated 30.3 million Uber shares, a ~1.4% stake worth about $2.3 billion.
Ackman described Uber as “one of the best-managed and highest-quality businesses in the world,” yet still “available at a massive discount to its intrinsic value.”
So is he right about Uber or will the bet flop?
» Read more about: Why Bill Ackman Bet $2.3 Billion That the Market Is Dead Wrong »
Read More
Is Cava’s Rapid Expansion a Risky Overstretch?
CAVA has been growing like a weed, now sporting 341 locations across 25 states. While the pace of new openings slowed slightly this year with just 33 new restaurants in the first 28 weeks of 2024 compared to 43 in 2023, the management still reported a solid 32.6% year-over-year revenue increase, and generated $487 million.
» Read more about: Is Cava’s Rapid Expansion a Risky Overstretch? »
Read More
1,432 Reasons to Buy This Healthcare Cloud Stock
Veeva Systems (NYSE:VEEV), a software solutions provider for the life sciences industry, has seen some weakness amid the slowdown in cloud market demand as organizations cope with macro woes.
While the company saw its shares slumping by around 32% over the past three years,
» Read more about: 1,432 Reasons to Buy This Healthcare Cloud Stock »
Read More
Is This Fintech Set To Explode?
Fintech lender and financial services provider SoFi (NASDAQ:SOFI) was among the companies hit hard by the stock crash of 2021. At its peak, the company’s shares traded at over $25. Today, the stock is priced under $10 per share.
Recent developments, however, have given SoFi some renewed momentum and opened up the strong possibility of a turnaround.
» Read more about: Is This Fintech Set To Explode? »
Read More
1 Under-the-Radar Pharma Stock with 90% Upside?
Billionaire Stanley Druckenmiller has been making large changes to his portfolio recently, leaving retail investors struggling to keep up with what the famous stock picker is thinking.
One of the smaller holdings in Druckenmiller’s portfolio that makes for interesting examination is ARS Pharmaceuticals (NASDAQ:SPRY).
Druckenmiller’s 536,900 shares of SPRY are currently valued at around $7 million.
» Read more about: 1 Under-the-Radar Pharma Stock with 90% Upside? »
Read MoreThe Ivy
Is This Cathie Wood Stock The Next Big Thing?
Tempus AI (NASDAQ:TEM) has seen its stock run all over the board since its IPO last year. The 52-week range for TEM shares runs from a low of $22.89 to a high of $91.45. This is perhaps unsurprising because Tempus is a young, innovative AI startup.
Since the start of 2025,
» Read more about: Is This Cathie Wood Stock The Next Big Thing? »
Read MoreThe Spotlight
1 High Energy Drink To Buy on the Dip?
Celsius Holdings (NASDAQ:CELH) is the maker of a line of energy drinks that has skyrocketed in popularity in recent years.
Once virtually unknown, Celsius has used social media marketing and celebrity influencer deals to rapidly build its brand awareness.
Although the product itself has been quite successful, the stock’s performance hasn’t matched it.
» Read more about: 1 High Energy Drink To Buy on the Dip? »
Read MoreThe Daily
S&P 500 futures tick higher after historic rally on Trump's tariff walkback: Live updates
Stocks fell Thursday, giving back some of the gains from the historic rally seen in the previous session after President Donald Trump announced a 90-day reprieve on some of his “reciprocal” tariffs. Investors worried that even with the short pause on some of the duties, economic activity will be slowed by Trump’s singling out of China with a much higher rate.